BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 22696597)

  • 1. NDRG2 correlated with favorable recurrence-free survival inhibits metastasis of mouse breast cancer cells via attenuation of active TGF-β production.
    Oh SS; Kim D; Kim DH; Chang HH; Sohn KC; Kim KH; Jung SH; Lee BK; Kim JH; Kim KD
    Carcinogenesis; 2012 Oct; 33(10):1882-8. PubMed ID: 22696597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NDRG2 is highly expressed in pancreatic beta cells and involved in protection against lipotoxicity.
    Shen L; Liu X; Hou W; Yang G; Wu Y; Zhang R; Li X; Che H; Lu Z; Zhang Y; Liu X; Yao L
    Cell Mol Life Sci; 2010 Apr; 67(8):1371-81. PubMed ID: 20127388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-educated Gr1+CD11b+ cells drive breast cancer metastasis via OSM/IL-6/JAK-induced cancer cell plasticity.
    Peyvandi S; Bulliard M; Yilmaz A; Kauzlaric A; Marcone R; Haerri L; Coquoz O; Huang YT; Duffey N; Gafner L; Lorusso G; Fournier N; Lan Q; Rüegg C
    J Clin Invest; 2024 Jan; 134(6):. PubMed ID: 38236642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NDRGs in Breast Cancer: A Review and In Silico Analysis.
    Villodre ES; Nguyen APN; Debeb BG
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Hypercoagulable Hematological Metastasis Breast Cancer Model.
    Yang WJ; Zhang GL; Cao KX; Yang GW
    Biomed Res Int; 2021; 2021():5473959. PubMed ID: 34485514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Function of N-Myc Downstream-Regulated Gene 2 (NDRG2) as a Negative Regulator in Tumor Cell Metastasis.
    Lee KW; Lim S; Kim KD
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-myc Downstream-Regulated Gene 2 (NDRG2) Function as a Positive Regulator of Apoptosis: A New Insight into NDRG2 as a Tumor Suppressor.
    Kim G; Lim S; Kim KD
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine TGF-β in Cancer: Review of the Literature and Caveats in Experimental Analysis.
    Ungefroren H
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low NDRG2 expression predicts poor prognosis in solid tumors: A meta-analysis of cohort study.
    Gu A; Xu J; Ye J; Zhang C
    Medicine (Baltimore); 2020 Oct; 99(41):e22678. PubMed ID: 33031336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Potentials of miR-576-3p, miR-613, NDRG2 and YKL40 in Colorectal Cancer Patients.
    Eldaly MN; Metwally FM; Shousha WG; El-Saiid AS; Ramadan SS
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1689-1695. PubMed ID: 32592365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NDRG2 Sensitizes Myeloid Leukemia to Arsenic Trioxide via GSK3β-NDRG2-PP2A Complex Formation.
    Park S; Han HT; Oh SS; Kim DH; Jeong JW; Lee KW; Kim M; Lim JS; Cho YY; Hwangbo C; Yoo J; Kim KD
    Cells; 2019 May; 8(5):. PubMed ID: 31121982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NDRG2 contributes to cisplatin sensitivity through modulation of BAK-to-Mcl-1 ratio.
    Park S; Oh SS; Lee KW; Lee YK; Kim NY; Kim JH; Yoo J; Kim KD
    Cell Death Dis; 2018 Jan; 9(2):30. PubMed ID: 29348517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients' Outcome in Basal-Like Breast Cancer.
    Kloten V; Schlensog M; Eschenbruch J; Gasthaus J; Tiedemann J; Mijnes J; Heide T; Braunschweig T; Knüchel R; Dahl E
    PLoS One; 2016; 11(7):e0159073. PubMed ID: 27400234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NDRG2 Expression Decreases Tumor-Induced Osteoclast Differentiation by Down-regulating ICAM1 in Breast Cancer Cells.
    Kim B; Nam S; Lim JH; Lim JS
    Biomol Ther (Seoul); 2016 Jan; 24(1):9-18. PubMed ID: 26759696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway.
    Wang J; Yin D; Xie C; Zheng T; Liang Y; Hong X; Lu Z; Song X; Song R; Yang H; Sun B; Bhatta N; Meng X; Pan S; Jiang H; Liu L
    Oncotarget; 2014 Sep; 5(18):8478-91. PubMed ID: 25261367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDRG2 controls COX-2/PGE₂-mediated breast cancer cell migration and invasion.
    Kim MJ; Kim HS; Lee SH; Yang Y; Lee MS; Lim JS
    Mol Cells; 2014 Oct; 37(10):759-65. PubMed ID: 25256221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDRG2 overexpression enhances glucose deprivation-mediated apoptosis in breast cancer cells via inhibition of the LKB1-AMPK pathway.
    Kim HS; Kim MJ; Lim J; Yang Y; Lee MS; Lim JS
    Genes Cancer; 2014 May; 5(5-6):175-85. PubMed ID: 25061501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma.
    Ma J; Liu W; Guo H; Li S; Cao W; Du X; Lei S; Hou W; Xiong L; Yao L; Li N; Li Y
    Breast Cancer Res; 2014 Mar; 16(2):R27. PubMed ID: 24636131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor NDRG2 tips the balance of oncogenic TGF-β via EMT inhibition in colorectal cancer.
    Shen L; Qu X; Ma Y; Zheng J; Chu D; Liu B; Li X; Wang M; Xu C; Liu N; Yao L; Zhang J
    Oncogenesis; 2014 Feb; 3(2):e86. PubMed ID: 24492480
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.